Growth Metrics

Elicio Therapeutics (ELTX) Other Working Capital Changes (2020 - 2025)

Elicio Therapeutics filings provide 4 years of Other Working Capital Changes readings, the most recent being -$237000.0 for Q4 2023.

  • On a quarterly basis, Other Working Capital Changes rose 88.43% to -$237000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$825000.0, a 54.21% decrease, with the full-year FY2025 number at -$901000.0, up 1.1% from a year prior.
  • Other Working Capital Changes hit -$237000.0 in Q4 2023 for Elicio Therapeutics, up from -$251000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $2.6 million in Q3 2020 to a low of -$3.1 million in Q4 2020.
  • Median Other Working Capital Changes over the past 4 years was -$222000.0 (2021), compared with a mean of -$188071.4.
  • The widest YoY moves for Other Working Capital Changes: up 443.28% in 2022, down 889.37% in 2022.
  • Elicio Therapeutics' Other Working Capital Changes stood at -$3.1 million in 2020, then surged by 93.38% to -$207000.0 in 2021, then tumbled by 889.37% to -$2.0 million in 2022, then surged by 88.43% to -$237000.0 in 2023.
  • The last three reported values for Other Working Capital Changes were -$237000.0 (Q4 2023), -$251000.0 (Q3 2023), and $170000.0 (Q2 2023) per Business Quant data.